Posts By: Rory O'Connor

Study identifies methods to support adoption of cutting-edge breast cancer therapy

Posted

MANHASSET, NY – Researchers at the Feinstein Institute for Medical Research and Northwell Health’s Department of Radiation Medicine have identified methods to increase use of the cutting-edge cancer radiation therapy, hypofractionation, in breast cancer patients. These findings, recently published in Advances in Radiation Oncology, demonstrate that most patients with breast cancer can be treated with… read more

posted in: Press Releases

Research study aims to identify new ways to treat seizures

Posted

MANHASSET, NY – Lenox Hill Hospital and The Feinstein Institute for Medical Research have been chosen as study site to identify biomarkers for focal seizures in patients with treatment-resistant epilepsy. Researchers hope the study, called Human Epilepsy Project (HEP) 2, will help better understand the long-term challenges of living with focal seizures and better pinpoint severity and… read more

posted in: Press Releases

Feinstein Institute, NIH launch groundbreaking clinical trial for new lupus medication

Posted

Trial examines use of synthetic endocannabinoid mimetic with no psychotropic properties to treat lupus inflammation MANHASSET, NY – Researchers at Northwell Health’s Feinstein Institute for Medical Research are leading a nationwide National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) sponsored clinical trial testing the efficacy of a synthetic cannabinoid derivative… read more

posted in: Press Releases